Navigation Links
Aspirus Heart & Vascular Institute Surgeon First in State to Implant Heart Device
Date:6/30/2010

AtriClip reduces stroke risk for a-fib patients.

Wausau, Wis. (PRWEB) June 30, 2010 -- Aspirus Heart & Vascular Institute cardiovascular surgeon John Johnkoski, M.D., on Friday, became the first physician in Wisconsin and one of only five in the nation to implant a heart device that greatly reduces the risk for stroke in patients with atrial fibrillation (a-fib).

A common heart condition that affects an estimated 2.5 million Americans, a-fib is an irregular heartbeat that is caused by a faulty electrical impulse. The abnormal heartbeat associated with a-fib can cause blood to pool in the left atrial appendage, a thumb-sized pouch on top of the heart where the majority of blood clots are thought to form.

The device implanted by Dr. Johnkoski, called the AtriClip Gillinov-Cosgrove Left Atrial Appendage Exclusion device, clamps off blood flow to the appendage and prevents blood from pooling. By cutting off the blood flow, the chances of a clot forming in this high-risk area and causing a stroke are greatly reduced.

“Unless someone with a-fib undergoes a surgical procedure, the only way to reduce their risk of stroke is to take a blood-thinning medication like Coumadin,” Dr. Johnkoski said. “Coumadin can be difficult for some people to handle and it doesn’t mix well with an active lifestyle, but the AtriClip implant can allow a person to get off it, which is a huge benefit.”

The AtriClip blocks blood flow to the appendage more effectively than other techniques and is designed to be implanted from the outside of the heart, avoiding contact with circulating blood.

“The AtriClip is more effective than a stapling method in completely closing off the area of the heart where blood can pool,” Dr. Johnkoski said. “Blocking off blood flow with this device prevents the formation of pockets or pouches where clots can develop and lowers the incidence of stroke in patients with a-fib.”

In addition to implanting the AtriClip device, Dr. Johnkoski also performs an advanced surgical procedure for a-fib called thoracoscopic ablation, or mini-maze. This procedure is a minimally-invasive technique that is performed through a few small incisions on a patient’s side.

Dr. Johnkoski has performed more than 160 surgical ablations and is a recognized leader in the field, as the Aspirus Heart & Vascular Institute is one of fewer than 50 centers in the country to offer the procedure.

For more information about a-fib and treatments for the condition, visit www.treatafib.org.

Contact: Greg Aune, 715.847.0479

# # #

Read the full story at http://www.prweb.com/releases/2010/06/prweb4206884.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Aspirus Eases Pain of Rapid Data Growth With an EMC Information Infrastructure
2. New research identifies modifiable risk factors for heart disease
3. Magnetic field measurements of the human heart at room temperature
4. Summit Medical Group hosts “Go Red Day” to Raise Awareness of Heart Disease and Stroke
5. Top 10 Ways to Avoid a Heart Attack This Super Bowl
6. Blood Thinner Combos Risky for Heart Attack Patients
7. HeartMath Offers Free Certificates that Celebrate Love and the Heart
8. Texas Health Dallas Launches Screening Program for Female Heart Disease
9. NHLBI funds preclinical tests on devices for infants and children with congenital heart defects
10. Surgery on beating heart thanks to robotic helping hand
11. Renowned Cardiologist Offers Heart Healthy Tips for the Holiday Season
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Aspirus Heart & Vascular Institute Surgeon First in State to Implant Heart Device
(Date:7/21/2017)... ORLEANS, La. (PRWEB) , ... July 21, 2017 ... ... to allow 4th-year medical students improve their chances of acceptance to a residency ... for those who have earned degrees outside the U.S. , According to data ...
(Date:7/21/2017)... ... July 21, 2017 , ... In the ... from the Multicenter Orthopaedics Outcome Network (MOON) demonstrated that patients could perform sports-related ... though activity levels decline over time. The study, presented today at the ...
(Date:7/20/2017)... ... July 20, 2017 , ... ChenMed , a ... joined JenCare Senior Medical Center as Richmond Chief Medical Officer. Dr. ... Medicine, and Associate Chief Medical Officer of Ambulatory Services for the UVA Health System, ...
(Date:7/20/2017)... ... July 20, 2017 , ... For individuals with extended hospital ... adjustable beds used in such facilities are specially designed to accommodate patients with a ... , An inventor from Rochester, Ind., has invented the patent-pending PORTABLE ARM REST, ...
(Date:7/20/2017)... MD (PRWEB) , ... July 20, 2017 , ... ... company dedicated to the development of non-invasive devices and systems for monitoring cardiopulmonary ... million. , Proceeds will be used to complete regulatory submissions and fund final ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017  Bayer has awarded grants totaling more ... part of its prestigious Bayer Hemophilia Awards Program (BHAP). Four ... Philadelphia and Uniformed Services University of the ... the winners. Grant recipients were announced last night during a ... 2017 Congress, Berlin, Germany . ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston Hotel, ... unparalleled access to global decision makers and innovative biotech ... life science leaders during two impactful days. BioPharm America ... delegates with additional networking opportunities with 4,500+ life science ...
Breaking Medicine Technology: